Breakthrough in Alzheimer's Research Recognized with Prestigious Morby Prize

The Cure Alzheimer’s Fund has announced the recipients of the second annual Jeffrey L. Morby Prize, recognizing Dr. Andrew S. Yoo and Dr. Zhao Sun for their groundbreaking research on Alzheimer’s disease (AD). Their study, published in Science in August 2024, introduces a novel method to model late-onset Alzheimer’s disease neuropathology through direct neuronal reprogramming, offering new avenues for research and treatment.

Alzheimer’s disease, a leading cause of dementia worldwide, has long posed significant challenges to researchers due to the difficulty of studying aged neurons in a lab setting without invasive procedures. The awarded research overcomes this hurdle by transforming skin cells from patients into neurons that accurately reflect the aging process. This innovation allows scientists to observe critical disease features, such as amyloid beta plaque buildup, in a controlled environment, providing invaluable insights into the disease's progression and potential intervention strategies.

The significance of this research extends beyond the laboratory. With over 6 million Americans living with Alzheimer’s and numbers expected to rise, the need for effective treatments has never been more urgent. The Morby Prize, named in honor of Cure Alzheimer’s Fund co-founder Jeffrey L. Morby, underscores the nonprofit’s commitment to funding research that pushes the boundaries of our understanding of Alzheimer’s disease. The $200,000 award will further support Dr. Yoo’s lab in exploring how aging contributes to neurodegeneration, potentially leading to targeted therapies for different neuronal subtypes.

This recognition highlights the importance of innovative approaches in tackling Alzheimer’s disease. By enabling the study of aged neurons without the need for brain biopsies, Dr. Yoo and Dr. Sun’s work opens up new possibilities for understanding the mechanisms of late-onset Alzheimer’s and developing treatments that could slow or reverse its progression. As the global community continues to grapple with the growing impact of Alzheimer’s, such advancements offer hope for millions of patients and families affected by this devastating disease.